Calidi Biotherapeutics Announces Agreement with Northwestern University for Exclusive Commercial Rights to their IND for Treatment of Malignant Glioma
LA JOLLA, Calif.–(BUSINESS WIRE)–#adenovirus–Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of stem